Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
AssigneesCumberland Pharmaceuticals Inc., Vanderbilt University
InventorsLeo PAVLIV, Bryan VOSS, James West, Erica Carrier
Life of this patent
Estimating the term…
Abstract
The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
Claims17
A method of treating cardiac failure in a human in need of treatment thereof, comprising administering a therapeutically effective amount of [1S-(1α,2α,3α,4α)]-2-[[3-[4-[(Pentylamino)carbonyl]-2-oxazolyl]-7-oxabicyclo[2.2.1]hept-2-yl]methyl]-benzenepropanoic acid (ifetroban) or a pharmaceutically acceptable salt thereof to the human.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
9-19. (canceled)
Dependencies are inferred from the claim text.